Questions to ask about hepatitis B monitoring

Follow-up is individualized

Chronic hepatitis B monitoring often considers HBV DNA, ALT/AST, HBeAg status, fibrosis or cirrhosis risk, age, family history, pregnancy plans, other conditions, current medicines, and local guidelines. Two people can both be HBsAg positive but need different follow-up intervals and different treatment decisions.

The goal of a follow-up visit is not only to show one new report. It is to clarify trends, risk, and the next plan. Ask the clinician which hepatitis B category best fits you now, which results are stable, which need monitoring, and which changes should make you contact the clinic earlier.

What to bring to the visit

Bring previous HBsAg, HBeAg/anti-HBe, HBV DNA, ALT/AST, bilirubin, albumin, INR, platelets, liver ultrasound, elastography, AFP, medication history, missed-dose notes, alcohol use, and supplement use. If family members have hepatitis B, cirrhosis, or liver cancer, write down that family history.

If you are planning pregnancy, are pregnant, may start chemotherapy or immune-suppressing treatment, or use long-term steroids or biologic medicines, say this clearly during follow-up. Monitoring or preventive antiviral treatment may need to be discussed before those situations begin.

Questions to ask the clinician

1. Which chronic hepatitis B phase or clinical category best describes me now?
2. What do my HBV DNA, ALT/AST, and platelet trends suggest?
3. Do I need fibrosis assessment, cirrhosis assessment, or liver cancer screening?
4. Do I meet criteria for antiviral treatment, or why is observation preferred for now?
5. Which tests should I repeat next, and how often?
6. Which symptoms or result changes should make me contact you earlier?
7. What should I do before pregnancy, surgery, chemotherapy, or immune-suppressing treatment?
8. Do family members or partners need screening, vaccination, or post-exposure information?

Turn the plan into one clear sentence

Before leaving the visit, try to write the plan in one sentence: next test date, test items, whether current medicines continue, whether ultrasound/AFP is needed, and what should trigger earlier care. This is easier to follow than only remembering to have regular follow-up.

If you take entecavir, tenofovir, or another antiviral, confirm what to do after missed doses, whether kidney or bone-related monitoring is needed, whether the medicine conflicts with other treatments, and whether stopping treatment could ever be discussed. Do not stop or switch antiviral medicines on your own.

Action checklist

Sort past reports by date. Build a trend table for HBV DNA, ALT/AST, platelets, ultrasound, and AFP. Write down the top three questions before the visit. Ask for the next test items and date. Ask what symptoms or results should prompt earlier contact. Before pregnancy, chemotherapy, immune-suppressing treatment, or surgery, proactively tell clinicians that you have hepatitis B.